Andrew Wegrzyn is a Principal at SixThirty, focusing on digital health and fintech. He previously led oncology innovation at Washington University School of Medicine and held roles at Citi Ventures and Edward Jones.
At firms with a similar stage, sector and check size.



One email when Andrew's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAndrew Wegrzyn is a Principal at SixThirty, focusing on digital health and fintech. He previously led oncology innovation at Washington University School of Medicine and held roles at Citi Ventures and Edward Jones.
SixThirty has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Andrew in the subject. A warm intro from a founder SixThirty backed works better.
led teams innovating new treatments in neuro and genitourinary oncology at Washington University School of Medicine; Vice President of Strategy and Partnership at Citi Ventures; consulted at Edward Jones.
Last updated 2026-10-15. Is this you? Ask for a correction.